Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012:3:1300.
doi: 10.1038/ncomms2270.

PPARγ is an E3 ligase that induces the degradation of NFκB/p65

Affiliations
Free article

PPARγ is an E3 ligase that induces the degradation of NFκB/p65

Yongzhong Hou et al. Nat Commun. 2012.
Free article

Abstract

Nuclear factor-κB (NFκB) and peroxisome proliferator activated receptor-γ (PPARγ) are both transcription factors that perform distinct but overlapping roles in cellular regulation. Here we report that PPARγ acts as an E3 ubiquitin ligase, physically interacting with p65 to induce its ubiquitination and degradation. The ligand-binding domain of PPARγ interacts with the Rel Homology Domain region of NFκB/p65 to undergo robust ubiquitination and degradation that was independent of PPARγ transcriptional activity. Moreover, the ligand-binding domain of PPARγ delivered Lys48-linked polyubiquitin, resulting in the ubiquitination and degradation of p65. Lys28 was found to be critically important for PPARγ-mediated ubiquitination and degradation of p65, as it terminated both NFκB/p65-mediated pro-inflammatory responses and xenograft tumours. These findings demonstrate that PPARγ E3 ubiquitin ligase activity induces Lys48-linked ubiquitination and degradation of p65, and that this function is critical to terminate NFκB signalling pathway-elicited inflammation and cancer.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Semin Cancer Biol. 2003 Apr;13(2):107-14 - PubMed
    1. Cell. 1999 May 14;97(4):427-30 - PubMed
    1. Cell Cycle. 2007 Jul 1;6(13):1539-48 - PubMed
    1. Nat Immunol. 2004 Jan;5(1):104-12 - PubMed
    1. J Biol Chem. 2003 Jul 25;278(30):28181-92 - PubMed

Publication types

LinkOut - more resources